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ABSTRACT 
At this era the world is suffering from many health dilemmas. Most of them are environmental, ecological, depending on several human races or 
ethnic background. Diabetes is one of them. Diabetes is chronic metabolic disorder which is group of diverse complications. The present study 
is overview of various 30 Ayurvedic polyherbal formulations and their significance as antidiabetic potential in diabetic rats. Models used are 
alloxon induced, streptozotocin induced and streptozotocin-nicotinamide induced diabetes. Plants have always been an exemplary source of 
drugs and many of the currently available drugs have been derived directly or indirectly from them. The Ayurveda and other Indian literature 
strongly believe; current scientific evidences, the use of medicinal plants in treatment of various human diseases is found significant. Diverse 
researches conducted in the last few decades on plants, mentioned in ancient literature or used traditionally for diabetes, have shown 
antidiabetic property. Further research should continue, especially in areas within nations that have received less attention.  
Keywords: Ayurvedic polyherbal formulation, Diabetes, Antidiabetic, Survey, Preclinical, Madhumeh  
 
Article Info: Received 06 July 2019;     Review Completed 14 Aug 2019;     Accepted 22 Aug 2019;     Available online 30 Aug 2019 
Cite this article as: 
Upasani SV, Bhandari GS, Upasani MS, Torne AA, Haswani NG, Ayurvedic Polyherbal Formulation and Diabetes: An 
Overview, Journal of Drug Delivery and Therapeutics. 2019; 9(4-A):779-784  http://dx.doi.org/10.22270/jddt.v9i4-
A.3517                                                                   
*Address for Correspondence:  
Mr. Sughosh Vishweshwar Upasani, SES’s R. C. Patel Institute of Pharmacy, Shirpur, 425405, Dhule, Maharashtra, India. 
 
 
DIABETES 
At this era the world is suffering from many health dilemmas. 
Most of them are geographical, ecological, depending on a 
variety of human races or ethnic backgrounds. Diabetes is 
one of them. Diabetes is chronic metabolic disorder which is 
group of different complications. At present India is leading 
the world in number of diabetes, furthermore it having 
second ranking in number of Prediabetes.1 As per 
International Diabetes Federation (IDF) Diabetes Atlas, the 
global Diabetes occurrence in the age group 20–79 years is 
estimated to be 6.6% for the year 2010 which convert into 
285 million people suffering from Diabetes.1, 2, 3 
Signs and Symptoms  
As per Indian Health Services (IHS), Australian Diabetes 
Society (ADS) and American Diabetes Association (ADA) 
following are some symptoms which observed - Constant 
hunger, Unexplained weight loss or weight gain, Flu-like 
symptoms, including weakness and fatigue, Blurred vision or 
visionary problems, Slow healing of cuts or bruises, Tingling 
or loss of feeling in hands or feet, Recurring gum or skin 
infections, and Recurring vaginal or bladder infections etc. 1-8 
Risk Factors  
Following are associated with insulin resistance and are risk 
factors for the development diabetes - Age ≥ 30 years, Family 
history of diabetes, Sedentary lifestyle, Metabolic syndrome, 
Cardiovascular disease, Hypertension or family history of 
cardiovascular diseases, Overweight or obese, Women who 
have had gestational diabetes, had high birth weight babies 
(greater than 9 lbs.), and/or has Polycystic Ovarian 
Syndrome (PCOS), Middle age women who has Large bra cup 
size at age 20.1, 4-7 
TREATMENT AND AYURVEDIC APPROACH 
The goals of early glucose-directed therapies are to 
normalize glucose levels, to prevent or delay progression to 
diabetes, and to prevent micro vascular complications.  
Plants have always been an exemplary source of drugs and 
many of the currently available drugs have been derived 
directly or indirectly from them. In India, diabetes has been 
known for a long time, but its incidence is not of the same 
magnitude across the subcontinent. The wide range of 
structures of the plant constituents, which appear to be the 
active hypoglycaemic principles, suggests different sites of 
action within the body. The plants provide a potential source 
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of hypoglycaemic drugs because many plants and plant 
derived compounds have been used in the treatment of 
diabetes. Several medicinal plants have found potential use 
as hypoglycaemic in the Indian system of medicines. A 
number of researches conducted in the last few decades on 
plants, mentioned in ancient literature or used traditionally 
for diabetes, have shown antidiabetic property. Among them, 
most off plants and their products (active natural principles 
and crude extracts) that have been mentioned used in the 
Indian traditional system of medicine have shown 
experimental or clinical antidiabetic activity.8 In Ayurved it is 
considered as ‘Naasti Moolam Anaushadhim’ - no plant 
present on Earth which isn’t having medicinal properties. 
The Ayurved and other Indian literature strongly believe; 
current scientific evidences, the use of medicinal plants in 
treatment of various human diseases is found significant. 
Diverse researches conducted in the last few decades on 
plants, mentioned in ancient literature or used traditionally 
for diabetes, have shown antidiabetic property.9 The Indian 
word for diabetes derived from Sanskrit literature Ayurved 
is “Madhumeha”. The Madhumeha is a combination of two 
“Madhu” means “sweet or sweetness” as like honey and 
“Meha” means “excessive urination”. All the renowned 
traditional texts of Ayurveda like Charaka Samhita (1000 
B.C.), Sushruta Samhita (600 B.C.) and subsequent works 
refer to this disease under the term Madhumeha or 
Ikshumeha (Ikshu means Sugarcane).[8] Indian plants which 
are most effective and the most commonly studied in relation 
to DM and their complications are 10-12 
  
1. Acacia Arabica  
2. Acacia nilotica  
3. Aegle marmelos 
4. Allium cepa 
5. Allium sativum 
6. Aloe vera 
7. Andrographis panicullata 
8. Areca catechu  
9. Azadirachta indica 
10. Berginia ciliata 
11. Beta vulgaris  
12. Biophytum sensitivum  
13. Bombax ceiba  
14. Brassica juncea  
15. Caesalpinia bonducella  
16. Cajanus cajan 
17. Coccinia indica 
18. Caesalpinia bonducella 
19. Curcuma longa 
20. Embelica officinalis 
21. Eucalyptus globulus  
22. Eugenia jambolana 
23. Enicostemma littorale 
24. Ficus bengalenesis  
25. Ficus glomerulata 
26. Glycerrhiza glabra  
27. Gymnema sylvestre 
28. Hibiscus rosa-sinesis  
29. Ipomoea batatas  
30. Lantana camara  
31. Magnifera indica 
32. Memecylon umbellatum  
33. Momordica cymbalaria  
34. Momordica charantia 
35. Morus alba  
36. Musa sapientum  
37. Mucuna pruriens  
38. Murraya koenigii 
39. Nelumbo nucifera  
40. Ocimum sanctum 
41. Panax ginseng 
42. Picrorrhiza kurroa  
43. Phyllanthus niruri  
44. Pterocarpus marsupium  
45. Punica granatum  
46. Salacia reticulata  
47. Salacia oblonga  
48. Swertia chirayita 
49. Syzigium cumini 
50. Termenalia arjuna  
51. Termenalia chebulla 
52. Tinospora cardifolia  
53. Trigonella foenum -  
54. Vinca rosea  
55. Withania somnefera  
56. Zingiber officinalis   
 
Methodology 
The current study provides a collection of information on 
Ayurvedic Polyherbal formulation and their evaluation on 
diabetes. The appropriate literature, including books, 
journals, and reports, was reviewed. The relevant 
information was searched using various electronic catalogs 
(e.g., Google Scholar, Science Direct, etc. ) and keywords such 
as “Ayurvedic Polyherbal formulation,” “Polyherbal,” 
“Ayurvedic formulation,” “Indian,” “diabetes,” and 
“Madhumeh”. It was difficult to include all the information. 
This study focused on information that would be easily 
accessible for researchers.13 Table number 01 is focusing 
some selected experimental preclinical antidiabetic 
activities. Figure number 01 and 02 will show frequency and 
number of plants used, and frequency of experimental model 
used respectively. 
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Table No. 01- Composition of Ayurvedic Polyherbal formulation and other details 
No. of 
Plants 
Ayurvedic Polyherbal formulation 
Experimental 
Model 
Extraction 
solvent 
Standard drug 
used 
Extraction 
Method 
Ref 
11 
Aegle marmelos, Annona squamosa, 
Bougain villia, Cassia auriculata, Emblica 
officinale, Ficus carica, Hybiscus 
rosasinensis, Psidium guajava, 
Tenospora cardifolia, Terminalia 
chebula, Zingiber officinale 
Alloxon 
Induced DM 
Aqueous Glibenclamide Decoction 15 
11 
Aegle marmelos, Annona squamosa, 
Azadirachta indica, Cajanus cajan, 
Cinnamomum tamala Ferula assafoetida, 
Gymnema sylvestre,  Moringa oleifera, 
Tamar indus indica, Trigonella foenum, 
Zingiber oficinale, 
Streptozotocin 
Induced DM 
Dried powder Glibenclamide 
Dried 
powder 
16 
10 
Azadirachta indica, Curcuma longa, 
Gymnema sylvestre, Momordica 
charantia, Paneer pera, Piper nigrum, 
Swerita chirayita, Syzygium cumini, 
Terminalia bellirica, Trigonella foenum, 
Alloxon 
Induced DM 
Hydroalcoholic Glibenclamide Maceration 17 
8 
Acacia catechu, Cassia auriculata, 
Hemidesmus indicus, Holarrhena 
antidysenterica, Salacia reticulata, 
Strychno spotatrum, Trigonella graecum, 
Vetiveria zizanioides 
Streptozotocin 
Induced DM 
Dried powder Glibenclamide 
Dried 
powder 
18 
8 
Azadirecta indica, Curcuma longa, 
Emblica officinale,  Enicostemma 
littorale, Gymnema sylvestre,Momordica 
charatia, Syzygium cumini, Tinospora 
cordiofolia, 
Streptozotocin 
Induced DM    
19 
6 
Caesalpenia bonduc, Citrullus lanatus, 
Evolvulus alsinoide , Gymnema sylvestra, 
Tinospora cordiofolia, Withania 
coagulans, 
Alloxon 
Induced DM 
Ethanol Glibenclamide Soxlet 20 
5 
Andrographis paniculata, Gymnema 
sylvestere, Momordica charantia, 
Pterocarpus marsupium, Tinospora 
cordifolia 
Alloxon 
Induced DM 
Methanol 
 
Maceration 21 
5 
Adiantium capillus, Astercantha 
longifolia, Callicarpa macrophylla, Ficus 
benghalensis, Melia azedarach 
Alloxon 
Induced DM 
Ethanol 
 
Succesive 
solvent 
extraction 
by soxlet 
22 
5 
Alstonia scholaris, Gymnema sylvestre, 
Holarrhena pubescens, Premna 
corymbosa, Solanum nigrum, 
Alloxon 
Induced DM 
Aqueous 
 
Maceration 23 
5 
Emblica officinalis, Gymnema sylvestre, 
Terminalia arjuna, Tinospora cordifolia, 
Zingiber officinale 
Nicotinamide 
Streptozotocin 
Induced DM 
Supercritical 
CO2  
Supercritic
al fluid 
extraction 
24 
5 
Andrographis paniculata, Eugenia 
jambolana, Gymnema sylvestre, 
Momordica charantia, Myristica fragrans 
Streptozotocin 
Induced DM 
Hydroalcoholic Glibenclamide 
Tripple 
maceration 
25 
5 
Camellia sinensis, Foeniculum vulgare, 
Macrotyloma uniflorum, Punica 
granatum, Trigonella foenum 
Streptozotocin 
Induced DM 
Ethanol Glibenclamide Soxlet 26 
5 
Gymnema sylvestre, Pterocarpus 
marsupium, Tinospora cordifolia 
Trigonella foenum 
Streptozotocin 
Induced DM 
Ethanol 
 
Maceration 27 
5 
Cassia auriculata, Cinnamomum tamala, 
Ficus banghalensis, Mangifera indica, 
Trichosynthis diocia 
Streptozotocin 
Induced DM 
Aqueous 
 
Maceration 28 
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5 
Azadirachta indica, Gymnema sylvestre, 
Momordica charantia, Syzigium cumini, 
Trigonella foenum 
Streptozotocin 
Induced DM 
Aqueous Glibenclamide 
Morter 
pastele 
29 
4 
Allium sativum, Ocimum gratissimum, 
Vernonia amygdalina, and Zingiber 
officinale 
Alloxon 
Induced DM 
Aqueous 
 
Cold 
maceration 
30 
3 
Eugenia jambolana, Momordica 
charantia, Ocimum sanctum 
Alloxon 
Induced DM 
Hydroalcoholic 
 
Soxlet 31 
3 
Piper nigrum, Ricinus Communis, 
Tribulus terrestris 
Alloxon 
Induced DM 
Ethanol Glibenclamide 
Cold 
maceration 
32 
3 
Alternanthera sessilis, Amaranthus 
viridis, Boerhavia diffusa 
Alloxon 
Induced DM 
Aqueous Glibenclamide Decoction 33 
3 
Caesalpinia bonducella, Mucona puriens, 
Pongamia pinnata 
Alloxon 
Induced DM 
Aqueous Glibenclamide 
Continuos 
hot soxlet 
34 
3 
Glycosmis pentaphylla, Mangifera indica, 
Tridax procumbens 
Nicotinamide 
Streptozotocin 
Induced DM 
Ethanol Glibenclamide Soxlet 35 
3 
Barleria Montana, Rotula aquatic, 
Schrebera swietenoides 
Streptozotocin 
Induced DM 
Methanol 
 
Soxlet 36 
3 
Portulaca oleracea, Spilanthe safricana, 
Sida rhombifolia 
Streptozotocin 
Induced DM 
Aqueous Glibenclamide Maceration 37 
3 
Azadirachta indica, Boerhavia diffusa, 
Tribulus terestris, 
Streptozotocin 
Induced DM 
Alcoholic Glibenclamide Maceration 38 
3 
Azadirachta indica, Andrographis 
paniculata, Moringa oleifera 
Streptozotocin 
Induced DM 
Hydroalcoholic 
 
Maceration 39 
3 
Gymnema sylvestre, Syzygium cumini, 
Urtica dioica 
Streptozotocin 
Induced DM 
Methanol 
 
Rotary 
shaking 
40 
3 
Azadirachta indica, Bougainvillea  
spectabilis, Trigonella  foenum 
Streptozotocin 
Induced DM 
Aqueous, 
cholorform, 
ethanol 
Glibenclamide Extraction 41 
3 
Azadirecta indica, Andrographis 
paniculata, Moringa oeifera 
Streptozotocin 
Induced DM 
Hydroalcoholic Glibenclamide Extraction 42 
2 
Camellia sinensis, Macrotyloma 
uniflorum 
Nicotinamide 
Streptozotocin 
Induced DM 
Methanol 
 
Maceration 43 
2 Annona squamosa, Phyllanthus emblica 
Streptozotocin 
Induced DM 
Aqueous Glibenclamide Decoction 44 
 
 
Figure No. 01 - Number of Plants used 
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Figure No. 02 - Experimental Model used 
 
DENOUEMENT 
One valuable gift to human health is provided by nature in 
the  form  of  medicinal  plants  in  the  locality  and  one  of  
the signiﬁcant  ways  in  which  humans  directly  reap  the  
beneﬁts provided  by biodiversity.14 In this overview of 
Ayurvedic Polyherbal formulation found that it has a 
significant effect on the diabetes. According to editorial from 
‘The Lancet’ special issue on diabetes as health crisis, near 
about 366 million people worldwide currently have diabetes 
mellitus. Estimation is also that this number wills increases 
by 552 million and about 470 million people with 
Prediabetes by 2030.45 Thus, by triangulation, it is probably 
still possible to document most of the knowledge  14, but 
further research should continue, especially in areas within 
nations that have received less attention.  
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